Mission Statement, Vision, & Core Values (2026) of Shenzhen Kingdom Sci-Tech Co., Ltd.

Founded in 1998 and listed on the Shanghai Stock Exchange in 2003 (stock code: 600446), Shenzhen Kingdom Sci-Tech Co., Ltd. has grown into a leading fintech services group with nearly 20 subsidiaries serving the full spectrum of China's regulated financial market and embedding AI, Big Data, Blockchain and Cloud into solutions that secured it a sustained leadership-particularly in securities brokerage where it commands over 30% market share; guided by a mission that channels roughly 15% of annual revenue into R&D (about ¥300 million in 2023), and quality controls that yielded a 99.8% product pass rate plus ISO 9001 certification, the company reports that 92% of clients rated their 2023 experience as "excellent" or "good" while pursuing a customer retention target of 85%, all aligned with a vision to evolve into an international, world-class intelligent biotechnology and smart-city technology brand that creates societal value and upholds core values of Customer First, Keep Promise, Continuous Improvement, Win‑Win‑Win Cooperation, Innovation and Excellence, and Honest, Integrity-based partnerships-reflected in a market capitalization of approximately 14.72 billion CNY as of November 19, 2025.

Shenzhen Kingdom Sci-Tech Co., Ltd (600446.SS) - Intro

• Founded: 1998; Shanghai Stock Exchange listing: 2003 (600446.SS)
• Market capitalization (as of 2025-11-19): ~14.72 billion CNY
• Organizational footprint: nearly 20 subsidiaries covering product development, integration, operations and services
• Primary regulated clients: participants under the People's Bank of China (PBOC), China Banking and Insurance Regulatory Commission (CBIRC) and China Securities Regulatory Commission (CSRC)

• Full-stack fintech provider: front-office trading systems, back-office clearing and settlement, risk and compliance platforms, wealth-management tech, and digital banking infrastructure
• Cross-sector expansion: digital healthcare platforms and smart city systems integrated with financial service capabilities
• Technology integration: production deployments incorporating AI models for risk scoring, Big Data analytics for market surveillance, Blockchain for settlement provenance, and Cloud for elastic delivery

• Longstanding leadership in securities brokerage technology with sustained market share leadership over the past two decades
• Securities brokerage sector share: greater than 30% across targeted product categories and institutional deployments
• Service coverage: solutions tailored for state-owned banks, joint-stock banks, securities firms, insurance companies, fund managers and third-party fintech integrators

• R&D-driven: sustained investment in algorithmic trading engines, low-latency matching, compliance automation and biometric security
• Modular platform approach: microservice architectures and cloud-native deployments to accelerate institutional rollout
• Data-first operations: Big Data lakes supporting real-time risk analytics and customer insight generation

• Investor profile and ownership flows: see integrated investor briefing and stakeholder analyses at Exploring Shenzhen Kingdom Sci-Tech Co., Ltd Investor Profile: Who's Buying and Why?

Shenzhen Kingdom Sci-Tech Co., Ltd (600446.SS) - Overview

Shenzhen Kingdom Sci-Tech Co., Ltd (600446.SS) centers its corporate direction on innovation, product excellence, and sustained customer satisfaction. The company's mission drives heavy investment in research and quality systems while aligning corporate governance and operations to measurable performance targets.

• Mission Statement: Deliver cutting-edge electronic and connectivity solutions through continuous R&D, rigorous quality control, and customer-centric service.
• Vision: Become a globally recognized leader in intelligent connectivity and electronic components, enabling partners and end-users to benefit from reliable, high-performance products.
• Core Values:
  • Innovation - prioritize breakthroughs and iterative improvement.
  • Quality - maintain strict manufacturing and inspection standards.
  • Customer Focus - design processes to maximize satisfaction and retention.
  • Integrity - operate transparently and compliantly, including ISO 9001 practices.
  • Collaboration - partner with clients and suppliers for mutual growth.

Key strategic priorities reflect these metrics and values:

• Maintain or increase R&D investment to sustain product leadership and support new product pipelines.
• Preserve high quality standards (99.8% pass rate) through expanded QA automation and supplier audits.
• Achieve and exceed an 85% customer retention rate by enhancing after-sales, warranty, and customization capabilities.
• Leverage ISO 9001-aligned processes to scale production while controlling defect rates and lead times.

For detailed corporate background and how the company creates value, see: Shenzhen Kingdom Sci-Tech Co., Ltd: History, Ownership, Mission, How It Works & Makes Money

Shenzhen Kingdom Sci-Tech Co., Ltd (600446.SS) - Mission Statement

Shenzhen Kingdom Sci-Tech Co., Ltd (600446.SS) positions itself as an innovation-driven intelligent biotechnology enterprise dedicated to creating value for social and human development. The company's mission and vision translate into measurable goals, customer-centric operations, and a values-driven culture that balances commercial performance with social responsibility.

• Vision: establish an international brand and continuously create value for social and human development through technology innovation and leadership.
• Customer focus: prioritize top customers' needs and challenges, delivering competitive, value-added products and professional services.
• Strategic ambition: become a world-class intelligent biotechnology enterprise contributing to better lives globally.
• Operational ethos: continuous improvement, honesty, integrity, cooperation, mutual benefit, respect for nature, and love for mankind.

Core strategic pillars supporting the mission:

• Innovation-led R&D and product pipeline acceleration.
• Customer-centric solution development and premium service models.
• Global brand expansion and cross-border collaborations.
• Sustainable practices and social-value initiatives integrated into business decisions.

How mission translates into business actions:

• R&D investments aligned with intelligent biotech: prioritizing automation, AI-driven assays, and platform compatibility to boost throughput and lower per-test costs.
• Value-added product strategy: move up the value chain from commodity reagents to integrated diagnostic solutions and services for clinical and industrial clients.
• Customer-centric units: dedicated account teams for top customers, tailored service-level agreements, and co-development partnerships to resolve critical pain points.
• Internationalization roadmap: targeted regulatory approvals, strategic distributors in Europe and SE Asia, and participation in global consortiums to raise brand recognition.

Governance and cultural commitments that underpin the mission:

• Ethics & integrity: transparent reporting, compliance with listing rules of 600446.SS, and strong internal controls.
• Collaborative culture: cross-disciplinary teams fostering open innovation and partner ecosystems.
• Respect for nature & social responsibility: sustainable procurement, community health programs, and employee wellbeing initiatives.
• Mutual benefits: aligning stakeholder incentives-customers, employees, suppliers, investors-to sustain long-term value creation.

Context, milestones, and resources for stakeholders can be explored further: Shenzhen Kingdom Sci-Tech Co., Ltd: History, Ownership, Mission, How It Works & Makes Money

Shenzhen Kingdom Sci-Tech Co., Ltd (600446.SS) - Vision Statement

• Customer First: Deliver measurable customer satisfaction through rapid service, accuracy, and tailored solutions; target customer satisfaction: 98%.
• Keep Promise: Maintain reliability across product delivery, regulatory compliance, and after-sales support; target on-time delivery and service response: 99%.
• Continuously Improve: Institutionalize PDCA cycles and lean practices across manufacturing and R&D; target reduction in defect rates: 40% in three years.
• Win-Win-Win Cooperation: Build partnerships that create value for customers, employees, and partners - measured by partner retention and joint-revenue growth targets of 15% YoY in cooperative projects.
• Innovation and Excellence: Allocate sustained investment to R&D to integrate AI, IoT, and digital diagnostics - target R&D investment: ~8% of annual revenue.
• Honesty, Integrity, Cooperation, Mutual Benefits: Embed ESG and ethical governance into operations with targets for reduced waste, transparent reporting, and community health initiatives.

• Integrated Customer Voice Program: closed-loop feedback channels, quarterly reviews with key accounts, and NPS-driven product roadmaps.
• Guaranteed Service SLAs: contractual SLAs for delivery and calibration with financial remedies and escalation protocols.
• R&D + Open Innovation: internal R&D coupled with academic and industry partnerships to accelerate AI-assisted diagnostics and IoT-enabled monitoring.
• Lean Operations & Quality Systems: Six Sigma, ISO-aligned processes, and digital traceability to drive continuous improvement and reduce DPPM.
• Stakeholder-Aligned Partnerships: co-development agreements and revenue-sharing models to achieve win-win-win outcomes.
• Governance & Ethics: compliance frameworks, supplier code of conduct, and community health programs reflecting honesty and mutual benefit.